Taysha Gene Therapies Overview
Taysha Gene Therapies Target Price
Analysts' 12-month price predictions for TSHA.
Get informed when a big investor buys or sells
+ FollowShare Price
$5.97
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-01-06 | Raymond JamesChris Raymond | $13 |  117.8% upside |  |
| 2026-01-05 | Wells FargoZachary Fadem | $11 | 84.3% upside | |
| 2025-12-04 | Goldman Sachs | $11 | 84.3% upside | |
| 2025-12-04 | UBS | $11 | 84.3% upside | |
| 2025-11-14 | Cantor FitzgeraldKristen Kluska | $13 | 117.8% upside | |
| 2025-11-05 | JMP Securities | $8 | 34% upside | |
| 2025-10-02 | Robert W. BairdJack Allen | $12 | 101% upside | |
| 2025-10-02 | NeedhamGil Blum | $10 | 67.5% upside | |
| 2024-08-14 | BMO CapitalKeith Tapper | $5 |  16.2% downside | |
| 2024-07-01 | Piper SandlerChristopher Raymond | $7 | 17.3% upside | |
| 2024-05-14 | JefferiesEun Yang | $8 | 34% upside | |
| 2024-04-09 | Raymond JamesChristopher Raymond | $9 | 50.8% upside | |
| 2023-02-01 | Jefferies | $1.5 | 74.9% downside | |
| 2021-10-19 | Morgan StanleyMatthew Harrison | $39 | 553.3% upside | |
| 2021-05-19 | Cantor FitzgeraldKristen Kluska | $44 | 637% upside | |